Pharma Tips

GSK gets $200m from White House

By: Pharma News | Views: 938 | Date: 18-Jul-2013

GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow over the increasing threat of antimicrobial resistance (AMR).GSK will get the money from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS).

GSK gets $200m from White House


GSK image

GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow over the increasing threat of antimicrobial resistance (AMR).

GSK will get the money from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS).

It is the first time that HHS has taken such a flexible approach with a private company: instead of putting its money into one or two named candidates, the US government will allow cash to be moved around GSK’s antibacterial portfolio.

A joint BARDA-GSK ‘oversight’ committee will monitor progress and decide on the allocation of funds: the parties say this will support the development of several drugs to fight antibiotic resistance and even to counter bioterrorism.

HHS will put up $40 million for the initial 18-month agreement and up to a total of $200 million if the deal is renewed over five years.

Washington’s move will strike a chord in Westminster: the UK government believes the threat of AMR - since there are fewer medicines in pharma’s pipeline to treat a rising number of antibiotic-resistant infections - is potentially ‘catastrophic’.

Many pharma companies have pulled their antibacterial R&D programmes due to a mixture of complex science and low returns, and earlier this week UK health secretary Jeremy Hunt warned the World Health Assembly in Geneva: “There are few public health issues of greater importance.”

He added: “We need stronger international partnerships and coalitions so that the threat of AMR is fully recognised and the responsibility for reducing it is shared.”

GSK’s US public-private deal would seem to fit the bill, with the manufacturer getting significant financial help from state coffers to sustain R&D in this area.

“There is an urgent need to address antibiotic resistance and new models are needed to deal with this challenging area of drug development,” said David Payne, head of GSK’s Antibacterial Discovery Performance Unit.

“We strongly believe that innovative public-private partnerships such as this are integral to solving this critical healthcare issue and we are delighted to work with BARDA in a more strategic way,” Payne concluded.

GSK has worked with BARDA before on research deals for vaccines and antibiotics development: in March, GSK and the Texas A&M System received US government approval to establish an influenza vaccine facility in Texas.

The manufacturer also has links with Europe’s Innovative Medicines Initiative and the Defense Threat Reduction Agency, part of the US Department of Defense.

Previous Page Next Page

People Searching On This Page:
  • antibiotics pipeline
  • barda vaccine

Related Pages


Job Opening as Ware House Officer in Pharma Company

Job Opening as Ware House Officer in Pharma Company

Jobs
Date:
24-Jan-2013  Views: 3837

Posted By - Upman Placements Pvt Ltd. Keywords - warehouse, store, store keeper, store incharge. Job Description - 1) Dispensing of raw material and p ...
Flu Season Gets an Early Start, CDC Says

Flu Season Gets an Early Start, CDC Says

Articles | Pharmacology | Disease
Date:
04-Dec-2012  Views: 1220

Influenza activity through November in theUnited States was much higher than lastyear at this time, according to surveillancedata reported today at a ...
Research Associate - Packaging development HRD House

Research Associate - Packaging development HRD House

Jobs | R & D | Mumbai
Date:
27-Jul-2011  Views: 1866

Job detail for the post of Research Associate - Packaging development in HRD House Mumbai, 3 to 5 years of experience. Apply for the job Now ! Search ...
Production Chemist - API HRD House

Production Chemist - API HRD House

Jobs | Production | Mumbai
Date:
15-Jul-2011  Views: 2089

Job detail for the post of Production Chemist - API in HRD House Mumbai Suburbs, 4 to 5 years of experience. Apply for the job Now ! Search Jobs in In ...
Potential  Targets in the Treatment of Brain Stroke

Potential Targets in the Treatment of Brain Stroke

Articles
Date:
15-Jun-2010  Views: 1706

The blood supply to the forebrain is derived from the two internal carotid arteries & the basilar artery. Their branches form anastomosis at the base ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

25  + 5 =     
Comments
People Searched About:
Antibiotics Pipeline   |   Barda Vaccine   |  
Google : 51 times | Yahoo : 16 times | Bing : 10 times |